Covered recipient · General Payments record
STACY MARIE SWANSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$589.81
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $333.57 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $83.52 | 5 |
| Lilly USA, LLC | $63.01 | 3 |
| Janssen Biotech, Inc. | $55.73 | 3 |
| Ethicon US, LLC | $30.69 | 1 |
| UCB, Inc. | $22.34 | 1 |
| GENZYME CORPORATION | $22.24 | 1 |
| Medtronic, Inc. | $21.91 | 1 |
| Tempus AI, Inc | $18.63 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $15.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.44 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108277230 | CMS |
| ABBVIE INC. | $14.25 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108277232 | CMS |
| ABBVIE INC. | $16.45 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108277234 | CMS |
| ABBVIE INC. | $15.32 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108277236 | CMS |
| ABBVIE INC. | $18.06 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108277238 | CMS |
| Ethicon US, LLC | $30.69 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077628058 | CMS |
| GENZYME CORPORATION | $22.24 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139986738 | CMS |
| Janssen Biotech, Inc. | $21.43 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078434593 | CMS |
| Janssen Biotech, Inc. | $13.89 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078435027 | CMS |
| Janssen Biotech, Inc. | $20.41 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078434166 | CMS |
| Lilly USA, LLC | $22.26 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135912939 | CMS |
| Lilly USA, LLC | $13.40 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135891080 | CMS |
| Lilly USA, LLC | $27.35 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135957157 | CMS |
| Medtronic, Inc. | $21.91 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117012639 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $15.50 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152278947 | CMS |
| Tempus AI, Inc | $18.63 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150259365 | CMS |
| UCB, Inc. | $22.34 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143161594 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.